End-stage kidney disease (ESKD) is a common and morbid disease that affects patients'
quality and length of life, representing a large portion of health care expenditure in the …

Background The use of central venous catheters (CVC) is associated with higher morbidity
and mortality, related to infectious complications, contributing to poorer clinical outcomes …

Objective Patients with end stage renal failure who require haemodialysis suffer morbidity
and mortality due to vascular access. Bioengineered human acellular vessels (HAVs) may …

Rational & Objective A key aspect of smooth transition to dialysis is the timely creation of a
permanent access. Despite early referral to kidney care, initiation onto dialysis is still …

Background Treatment of end-stage kidney disease (ESKD) with hemodialysis requires
surgical creation of an arteriovenous (AV) vascular access—fistula (AVF) or graft (AVG)—to …

Rationale & Objective As the proportion of arteriovenous fistulas (AVFs) compared with
arteriovenous grafts (AVGs) in the United States has increased, there has been a concurrent …

Objective A systematic review and meta-analysis of randomised controlled trials (RCTs) was
performed to determine the effectiveness and safety of drug coated balloon (DCB) …

Abstract Objective Tunneled dialysis catheters (TDCs) are generally used as a temporary
means to provide hemodialysis until permanent arteriovenous (AV) access is established …

Background Controversy exists regarding the best-performing vascular access type for
patients undergoing haemodialysis. We aimed to compare outcomes of starting dialysis on …

Vascular access is the Achilles heel for hemodialysis (HD). An arteriovenous fistula (AVF),
considered the optimal access for HD, rather than a graft or central venous catheter (CVC) …